Synthesis and biological activity of novel S-Adenosyl-L-homocysteine hydrolase inhibitors

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 15, 2003, Pages 3229-3236

  Steere, Jennifer A ^a   Honek, John F ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3' AMINO 3' DEOXYADENOSINE; 4 (ADENIN 9 YL) 2,3 DIHYDROXYBUTANAL OXIME; 9 (5' DEOXY 5' METHYLTHIO DEXTRO RIBITYL)ADENINE; ADENOSYLHOMOCYSTEINASE; ENZYME INHIBITOR; HYDROLASE; HYDROLASE INHIBITOR; LIVER ENZYME; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; [4 (ADENIN 9 YL) 2,3 DIHYDROXYBUTYL ALPHA AMINO]BUTANOIC ACID;

ANIMAL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; INHIBITION KINETICS; LIVER; METABOLISM; NONHUMAN; RAT; SYNTHESIS; TIME;

EID: 0038016563     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00301-8     Document Type: Article

References (52)

1. (a) Ueland P.M. Pharm. Rev. 34:1982;223.
2. (b) Wolfe M.S., Borchardt R.T. J. Med. Chem. 34:1991;1521.
3. (c) Wolfe M. S.; Cantoni, G. L.; Chiang P.K. Cavallini D., Gaulle G.E., Zappia V. Natural Sulfur Compounds. Novel Biochemical and Structural Aspects. 1980;67 Plenum, New York.
4. (d) Turner M.A., Yang X., Yin D., Kuczera K., Borchardt R.T., Howell P.L. Cell Biochem. Biophys. 33:2000;101.
5. (e) Chiang P.K. Pharmacol. Ther. 77:1998;115.
6. (a) Takusagawa F., Fujioka M., Spies A., Schowen R.L. In Comprehensive Biological Catalysis: A Mechanistic Reference, Sinnott, M., Ed.; Academic: San Diego, 1998; pp 1.
7. (b) Drahovsky D., Boehm T.L.J. Int. J. Biochem. 12:1980;523.
8. (c) Cheng X., Blumenthal R.M. S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions. 1999;World Scientific, Singapore.
9. (a) de la Haba, G.; Cantoni, G. L., J. Biol. Chem., 1959, 234, 603.
10. (b) Chiang, P. K., In Methods in Pharmacology, Paton, D. M., Ed.; Plenum: New York, 1985; Vol 6, p. 127.
11. (a) Bray M., Driscoll J., Huggins J.W. Antiviral Res. 45:2000;135.
12. (b) Liu S., Wolfe M.S., Borchardt R.T. Antiviral Res. 19:1992;247.
13. (c) De Clercq E., Bergstron D.E., Holy A., Montgomery J.A. Antiviral Res. 4:1984;119.
14. (a) Bitonti A.J., Baumann J., Varvi T., McCarthy J.R., McCann P.P. Biochem. Pharmacol. 40:1990;601.
15. (b) Whaun J.M., Miura G.A., Brown N.D., Gordon R.K., Chiang P.K. J. Pharmacol. Exp. Ther. 236:1986;277.
16. (c) Nakanishi M., Iwata A., Yatome C., Kitade Y. J. Biochem. 129:2001;101.
17. Wolos J.A., Frondorf K.A., Esser R.E. J. Immunol. 151:1993;526.
18. (a) Saso Y., Conner E.M., Teegarden B.R., Yuan C.S. Pharmacology. 296:2001;106.
19. (b) Wolos J.A., Frondorf K.A., Davies G.F., Jarvi E.T., McCarthy F.R., Bowlin T.L. J. Immunol. 150:1993;3264.
20. Banerjee A.K. Microbiol. Rev. 44:1980;175.
21. (a) Andrei G., De Clercq E. Antiviral Res. 14:1990;287.
22. (b) Villalon M.D.G., Gil-Fernandez C., De Clercq E. Antiviral Res. 20:1993;131.
23. (c) Snoeck R., Andrei G., Neyts J., Schols D., Cools M., Balzarini J., De Clercq E. Antiviral Res. 21:1993;197.
24. (a) Hu Y., Komoto J., Huang Y., Gomi T., Ogawa H., Takata Y., Fujioka M., Takusagawa F. Biochemistry. 38:1999;8323.
25. (b) Komoto J., Huang Y., Gomi T., Ogawa H., Takata Y., Fujioka M., Takusagawa F. J. Biol. Chem. 275:2000;32147.
26. Turner M.A., Yuan C.S., Borchardt R.T., Hershfield M.S., Smith G.D., Howell P.L. Nature Struct. Biol. 5:1998;369.
27. Huang Y., Komoto J., Takata Y., Powell D.R., Gomi T., Ogawa H., Fujioka M., Takusagawa F. J. Biol. Chem. 277:2002;7477.
28. (a) Suhadolnik R.J. Nucleosides as Biological Probes. 1979;Wiley-Interscience, New York. p. 96
29. (b) Kutateladze T., Beabealashvilt R., Azhayev A., Krayevsky A. FEBS Lett. 153:1983;420.
30. (a) Holy A., Votruba I., De Clercq E. Collect. Czech. Chem. Commum. 50:1985;262.
31. (b) De Clercq E., Holy A. J. Med. Chem. 22:1979;510.
32. De Clercq E., Holy A. J. Med. Chem. 28:1985;282.
33. De Clercq E., Bergstron D.E., Holy A., Montgomery J.A. Antiviral Res. 4:1984;119.
34. Samano M.C., Robins M.J. Tetrahedron Lett. 30:1989;2329.
35. Hirota K., Monguchi Y., Sajiki H., Sako M., Kitade Y. J. Chem. Soc., Perkin Trans. 1. 1998;941.
36. (a) Hirota K., Kitade Y., Maki Y. Tetrahedron Lett. 34:1993;4835
37. (b) Hirota K., Monguchi Y., Kitade Y., Sajiki H. Tetrahedron. 53:1997;16683.
38. Evans M.E., Parrish F.W., Long L. Jr. Carbohydrate Res. 3:1967;453.
39. (a) Gomi T., Date T., Ogawa H., Fujioka M., Akasmit R.R., Backlund P.S., Cantoni G.L. J. Biol. Chem. 264:1989;1618.
40. (b) Steere J.A., Sampson P.B., Honek J.F. Bioorg. Med. Chem. Lett. 12:2002;457.
41. Mehdi S., Jarvi E.T., Koehl J.R., McCarthy J.R., Bey P. J. Enzym. Inhib. 4:1990;1.
42. Chiang P.K., Richards H.H., Cantoni G.L. Mol. Pharmacol. 13:1977;939.
43. Kitz R., Wilson I.B. J. Biol. Chem. 237:1962;3245.
44. (a) Guillerm G., Guillerm D., Vandenplas-Witkowski C., Rogniaux H., Carte N., Leize E., Van Dorsselaer A., De Clercq E., Lambert C. J. Med. Chem. 44:2001;2743
45. (b) Yuan C.S., Wnuk S.F., Liu S., Robins M.J., Borchardt R.T. Biochemistry. 33:1994;12305.
46. Silverman, R. B., In Methods in Enzymology, Purich, D. L., Ed.; Academic Press: New York, 1995; Vol. 249, p. 240.
47. Copeland R.A. Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis. 1996;Wiley-VCH, New York. p. 202.
48. Ragione F.D., Pegg A.E. Biochem. J. 210:1983;429.
49. Kajander E.O., Raina A.M. Biochem. J. 193:1981;503.
50. Wnuk S.F., Yuan C.S., Borchardt R.T., Balzarini J., De Clercq E., Robins M.J. J. Med. Chem. 40:1997;1608.
51. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265.
52. Riddles P.W., Blakeley R.L., Zerner B. Purich D.L. Methods in Enzymology. 1983;Academic Press, Inc, New York. Vol. 91, p. 49.